<DOC>
	<DOCNO>NCT01346943</DOCNO>
	<brief_summary>The purpose study evaluate safety deploy implant Altura Abdominal Aortic Aneurysm ( AAA ) Endograft treatment abdominal aortic aneurysm subject candidate open surgical aneurysm repair .</brief_summary>
	<brief_title>The Altura Abdominal Aortic Aneurysm ( AAA ) Endograft Safety Feasibility Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>18 year old . Subject subject 's legal representative understands sign informed consent . Infrarenal aneurysmal neck diameter 18 28mm , inclusive . Abdominal aneurysm neck angulation &lt; 45 degree . Infrarenal nonaneurysmal neck &gt; /= 15mm length . Abdominal aneurysm &gt; 4.5cm growth &gt; 1.0 cm/yr . Limited iliac artery tortuosity . Iliac artery fixation length &gt; /= 15mm . Iliac artery diameter 8 19 mm , inclusive . Iliac artery diameter accessible 14 Fr introducer . Subject candidate open surgical repair abdominal aortic aneurysm . Patent iliac femoral artery access vessel , size morphology allow endovascular access 14 Fr introducer sheath catheter . Subject &gt; one year life expectancy . Subject place additional risk wait additional imaging necessary vascular treatment . Subject American Society Anesthesiology ( ASA ) grade 1 3 , inclusive . Subject able willing comply 30 day , six ( 6 ) month , one ( 1 ) year 2 ( two ) year followup . Subject acutely rupture leaking emergent aneurysm . Subject dissect aneurysm . Subject mycotic infect aneurysm . Subject current vascular injury due trauma . Subject 's aneurysm thoracic suprarenal . Previous surgical endovascular aneurysm repair abdominal aortic aneurysm . Subject thrombus , calcification and/or plaque may compromise seal Subject myocardial infarction within six ( 6 ) month prior enrollment . Subject current angina active cardiac condition congestive heart failure , untreated worsen atrial arrhythmia , ventricular arrhythmia , valvular disease . Subject undergone major surgery within 30 day prior enrollment . Subject pregnant nursing . Known allergy nitinol polyester contrast material pretreated . Subject morbidly obese clinical condition severely inhibit Xray visualization aorta . Subject connective tissue disease ( e.g. , Marfan 's syndrome ) . Subject bleed disorder anemia define hemoglobin &lt; 9.0 mg/dL . Subject hypercoagulable . Subject dialysis compromise renal function reflect serum creatinine &gt; 2.2 mg/dL . Subject compromise hepatic function measure SGPT ( ALT ) &gt; three ( 3 ) time upper limit normal . Subject active systemic infection . Subject participate another research study involve investigational agent treatment AAA . Subject medical , social psychological problem , opinion investigator , preclude receive treatment procedure evaluation pre posttreatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Abdominal Aortic Aneurysms , AAA</keyword>
</DOC>